Status:
UNKNOWN
Understanding Non-radiotherapy-based Development of Trismus
Lead Sponsor:
KU Leuven
Conditions:
Trismus
Oral Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A limited mouth opening (or trismus) after surgery for oral cancers is not only one of the most common complications, but it is also a major contributing factor towards an impaired quality of life aft...
Eligibility Criteria
Inclusion
- All patients with a newly diagnosed oral cancer.
- Cases with a limited mouth opening secondary to oral tumour resections
Exclusion
- Minors.
- Deceased cases within the follow-up period of one year.
- Other malignancies than oral squamous cell carcinomas.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT04670146
Start Date
July 1 2020
End Date
December 1 2023
Last Update
December 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Omfs-Impath
Leuven, Vlaams-Brabantt, Belgium, 3000